In the past week, the Panacea Life Sciences Holdings (OTCMKTS:PLSH) stock has been in the middle of a fairly strong rally and has managed to bring in gains of as much as 10% as a consequence.
Market Action
On Thursday, PLSH stock ended flat at $0.66 with 1k shares, compared to its average volume of 5.3K shares. The stock has moved within a range of $0.6600 – 0.6600 after opening trade at $0.66.
New CBDA Oil Drops are Now Available for Purchase Online at panacealife.com
The CBD research company, which is based out of Colorado, was actually in the news yesterday after it made an announcement with regards to its CBDA Oil Drops product. Panacea Life Sciences announced yesterday that the product, which also contains Zinc and Vitamin D, had been made available for purchase from the website Panacealife.com. It was another important development for the company and one that might lead to more excitement among investors.
In this context, it is also necessary to note that CBD has the potential of having a wide range of health benefits. As a matter of fact, studies conducted recently by the University of Chicago and Oregon State University have suggested that CBD has a positive impact on human cells as well.
In light of that, it is a positive developments for Panacea Life Sciences as well, considering the fact that the company is involved in CBD research in a big way. At this point, it may be a good move to add the stock to your watch lists.
Key Quote
According to Panacea’s Chief Science Officer, James Baumgartner, Ph.D., “Panacea’s new CBDA Oil Drops not only contain a significant amount of both cannabinoids, but also have additional immunity-building ingredients to give our customers a terrific new product to naturally support the body’s immune system. The new information discovered in these studies is encouraging and paramount for Panacea. As a leading cannabinoid research company, our goal to conduct further research and studies that can positively impact the medical community.”
Traders Note
PLSH stock is trading below the 20-Day and 50-Day Moving averages of $0.72 and $0.79. Moreover, the stock is trading is the neutral zone with RSI stands at 47. The stock is down 25% over the past month.